Comparison of the hemodynamic effects of the patient position (sitting, right and left lateral position) during induction of spinal anesthesia for caesarean sectio
Not Applicable
Recruiting
- Conditions
- Cesarean section.Single liveborn infant, delivered by cesareanZ38.01
- Registration Number
- IRCT20120215009014N412
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 105
Inclusion Criteria
Age of 18 to 40 years;
Pregnant women candidate for cesarean section;
Exclusion Criteria
Multipara;
Cardiovascular disease or diabetes or preeclampsia;
Coagulopathy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure. Timepoint: ??At 1, 2, 3, 4, 5, 10, 15 and 20 minutes after spinal anesthesia. Method of measurement: With a monitor.;Heart rate. Timepoint: ??At 1, 2, 3, 4, 5, 10, 15 and 20 minutes after spinal anesthesia. Method of measurement: With a monitor.
- Secondary Outcome Measures
Name Time Method Side effects (nausea, vomiting and chilling). Timepoint: 20 minutes after spinal anesthesia. Method of measurement: With history taking.;Neonatal Apgar score. Timepoint: At 1 and 5 minutes after cesarean section. Method of measurement: With clinical examination.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does patient positioning during spinal anesthesia influence hemodynamic parameters in IRCT20120215009014N412 cesarean trials?
What comparative effectiveness data exist for sitting vs. lateral positions in preventing maternal hypotension during spinal anesthesia for cesarean?
Which physiological biomarkers correlate with hemodynamic stability in IRCT20120215009014N412 cesarean section positioning studies?
What adverse events are reported in IRCT20120215009014N412 for spinal anesthesia positioning, and how do they compare to standard-of-care management?
How does IRCT20120215009014N412 non-pharmacological positioning compare to vasopressor use for hypotension prevention in cesarean spinal anesthesia?